Exceeds fourth quarter and fiscal year revenue guidance Delivers record cash flow from operations of $807 million and adjusted free cash flow of $626 million in the fiscal yearReturns $258 million to ...
Minovia Therapeutics Ltd. ("Minovia" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback